Effects of dietary fucoxanthin on cholesterol metabolism in diabetic/obese KK-Ay mice

Lipids in Health and Disease

Volumn 11, Issue , 2012, Pages

  Beppu, Fumiaki ^a   Hosokawa, Masashi ^a   Niwano, Yoshimi ^b   Miyashita, Kazuo ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Cholesterol metabolism; Fucoxanthin; Liver; Low density lipoprotein (LDL) receptor (LDLR); Proprotein convertase subtilisin kexin type 9 (PCSK9); Scavenger receptor class B type 1 (SR B1); Sterol regulatory element binding protein (SREBP)

Indexed keywords

CHOLESTEROL; FUCOXANTHIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; KEXIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; SCAVENGER RECEPTOR BI; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; SUBTILISIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL LIVER LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DIET; DRUG MECHANISM; GENE; GENE EXPRESSION; GENE TARGETING; LYSOSOME; MALE; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADIPOSE TISSUE, WHITE; ADMINISTRATION, ORAL; ANIMALS; ANTI-OBESITY AGENTS; CHOLESTEROL; EPIDIDYMIS; GENE EXPRESSION; HYDROXYMETHYLGLUTARYL COA REDUCTASES; LIVER; MALE; MICE; MICE, OBESE; MUSCLE, SKELETAL; OBESITY; ORGAN SIZE; PROPROTEIN CONVERTASES; SERINE ENDOPEPTIDASES; XANTHOPHYLLS;

MUS; RODENTIA;

EID: 84865836821     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-11-112     Document Type: Article

References (36)

1. Fucoxanthin induces apoptosis and enhances the antiproliferative effect of the PPARgamma ligand, troglitazone, on colon cancer cells. Hosokawa M, Kudo M, Maeda H, Kohno H, Tanaka T, Miyashita K, Biochim Biophys Acta 2004 1675 113 119 10.1016/j.bbagen.2004.08.012 15535974
2. Effects of fucoxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo. Shiratori K, Ohgami K, Ilieva I, Jin XH, Koyama Y, Miyashita K, Yoshida K, Kase S, Ohno S, Exp Eye Res 2005 81 422 428 10.1016/j.exer.2005. 03.002 15950219
3. Radical scavenging and singlet oxygen quenching activity of marine carotenoid fucoxanthin and its metabolites. Sachindra NM, Sato E, Maeda H, Hosokawa M, Niwano Y, Kohno M, Miyashita K, J Agric Food Chem 2007 55 8516 8522 10.1021/jf071848a 17894451
4. Fucoxanthin regulates adipocytokine mRNA expression in white adipose tissue of diabetic/obese KK-Ay mice. Hosokawa M, Miyashita T, Nishikawa S, Emi S, Tsukui T, Beppu F, Okada T, Miyashita K, Arch Biochem Biophys 2010 504 17 25 10.1016/j.abb.2010.05.031 20515643
5. Safety evaluation of fucoxanthin purified from undariapinnatifida. Kadekaru T, Toyama H, Yasumoto T, Nippon Shokuhin Kagaku Kogaku Kaishi 2008 55 304 308 10.3136/nskkk.55.304
6. Single and repeated oral dose toxicity study of fucoxanthin (FX), a marine carotenoid, in mice. Beppu F, Niwano Y, Tsukui T, Hosokawa M, Miyashita K, J Toxicol Sci 2009 34 501 510 10.2131/jts.34.501 19797858
7. Fucoxanthin supplementation improves plasma and hepatic lipid metabolism and blood glucose concentration in high-fat fed C57BL/6N mice. Woo MN, Jeon SM, Kim HJ, Lee MK, Shin SK, Shin YC, Park YB, Choi MS, Chem Biol Interact 2010 186 316 322 10.1016/j.cbi.2010.05.006 20519145
8. Fucoxanthin and fucoxanthinol enhance the amount of docosahexaenoic acid in the liver of KKAy obese/diabetic mice. Tsukui T, Konno K, Hosokawa M, Maeda H, Sashima T, Miyashita K, J Agric Food Chem 2007 55 5025 5029 10.1021/jf070110q 17536824
9. Fucoxanthin-rich seaweed extract suppresses body weight gain and improves lipid metabolism in high-fat-fed C57BL/6J mice. Jeon SM, Kim HJ, Woo MN, Lee MK, Shin YC, Park YB, Choi MS, Biotechnol J 2010 5 961 969 10.1002/biot. 201000215 20845386
10. A simple method for the isolation and purification of total lipides from animal tissues. Folch J, Lees M, Sloane Stanley GH, J Biol Chem 1957 226 497 509 13428781
11. SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element. Hua X, Yokoyama C, Wu J, Briggs MR, Brown MS, Goldstein JL, Wang X, Proc Natl Acad Sci USA 1993 90 11603 11607 10.1073/pnas.90.24.11603 7903453
12. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Brown MS, Goldstein JL, Cell 1997 89 331 340 10.1016/S0092-8674(00)80213-5 9150132
13. Tissue-specific hepatic deletion of ABCA1 indicates that the liver is the primary site for HDL formation in vivo [abstract]. Timmins JM, Lee JY, Mulya A, Arterioscler Thromb Vasc Biol 2004 24 52
14. Lowering LDL - not only how low, but how long? Brown MS, Goldstein JL, Science 2006 311 1721 1723 10.1126/science.1125884 16556829
15. Dual regulation of the LDL receptor-some clarity and new questions. Attie AD, Seidah NG, Cell Metab 2005 1 290 292 10.1016/j.cmet.2005.04.006 16054075
16. Fucoxanthin from edible seaweed, Undaria pinnatifida, shows antiobesity effect through UCP1 expression in white adipose tissues. Maeda H, Hosokawa M, Sashima T, Funayama K, Miyashita K, Biochem Biophys Res Commun 2005 332 392 397 10.1016/j.bbrc.2005.05.002 15896707
17. The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat. Abidov M, Ramazanov Z, Seifulla R, Grachev S, Diabetes Obes Metab 2010 12 72 81 10.1111/j.1463-1326.2009.01132.x 19840063
18. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Rigotti A, Trigatti BL, Penman M, Rayburn H, Herz J, Krieger M, Proc Natl Acad Sci USA 1997 94 12610 12615 10.1073/pnas.94.23.12610 9356497
19. Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol. Varban ML, Rinninger F, Wang N, Fairchild-Huntress V, Dunmore JH, Fang Q, Gosselin ML, Dixon KL, Deeds JD, Acton SL, Tall AR, Huszar D, Proc Natl Acad Sci USA 1998 95 4619 4624 10.1073/pnas.95.8.4619 9539787
20. Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice. Wang N, Arai T, Ji Y, Rinninger F, Tall AR, J Biol Chem 1998 273 32920 32926 10.1074/jbc.273.49.32920 9830042
21. A receptor-mediated pathway for cholesterol homeostasis. Brown MS, Goldstein JL, Science 1986 232 34 47 10.1126/science.3513311 3513311
22. The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues. Rigotti A, Miettinen HE, Krieger M, Endocr Rev 2003 24 357 387 10.1210/er.2001-0037 12788804
23. ABCA1 and atherosclerosis. Soumian S, Albrecht C, Davies AH, Gibbs RG, Vasc Med 2005 10 109 119 10.1191/1358863x05vm593ra 16013195
24. Effects of dietary cholesterol on the regulation of total body cholesterol in man. Quintão E, Grundy SM, Ahrens EH, J Lipid Res 1971 12 233 247 5108133
25. Studies on the compartmentation of lipid in adipose cells. II. Cholesterol accumulation and distribution in adipose tissue components. Farkas J, Angel A, Avigan MI, J Lipid Res 1973 14 344 356 9704080
26. NARC-1/PCSK9 and its natural mutants: zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol. Benjannet S, Rhainds D, Essalmani R, Mayne J, Wickham L, Jin W, Asselin MC, Hamelin J, Varret M, Allard D, Trillard M, Abifadel M, Tebon A, Attie AD, Rader DJ, Boileau C, Brissette L, Chrétien M, Prat A, Seidah NG, J Biol Chem 2004 279 48865 48875 10.1074/jbc.M409699200 15358785
27. Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin/kexin type 9a in mouse liver. Park SW, Moon YA, Horton JD, J Biol Chem 2004 279 50630 50638 10.1074/jbc.M410077200 15385538
28. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Zelcer N, Hong C, Boyadjian R, Tontonoz P, Science 2009 325 100 104 10.1126/science.1168974 19520913
29. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation. Seidah NG, Benjannet S, Wickham L, Marcinkiewicz J, Jasmin SB, Stifani S, Basak A, Prat A, Chretien M, Proc Natl Acad Sci USA 2003 100 928 933 10.1073/pnas.0335507100 12552133
30. Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation. Zhang DW, Lagace TA, Garuti R, Zhao Z, McDonald M, Horton JD, Cohen JC, Hobbs HH, J Biol Chem 2007 282 18602 18612 10.1074/jbc.M702027200 17452316
31. Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin/kexin type 9a in mouse liver. Park SW, Moon YA, Horton JD, J Biol Chem 2004 279 50630 50638 10.1074/jbc.M410077200 15385538
32. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Horton JD, Shah NA, Warrington JA, Anderson NN, Park SW, Brown MS, Goldstein JL, Proc Natl Acad Sci USA 2003 100 12027 12032 10.1073/pnas.1534923100 14512514
33. Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mice. Maxwell KN, Soccio RE, Duncan EM, Sehayek E, Breslow JL, J Lipid Res 2003 44 2109 2119 10.1194/jlr.M300203-JLR200 12897189
34. The role of the high-density lipoprotein receptor SR-BI in cholesterol metabolism. Trigatti B, Rigotti A, Krieger M, Curr Opin Lipidol 2000 11 123 131 10.1097/00041433-200004000-00004 10787173
35. Oxysterol-activated LXRalpha/RXR induces hSR-BI-promoter activity in hepatoma cells and preadipocytes. Malerød L, Juvet LK, Hanssen-Bauer A, Eskild W, Berg T, Biochem Biophys Res Commun 2002 299 916 923 10.1016/S0006-291X(02)02760-2 12470667
36. Fibrates down-regulate hepatic scavenger receptor class B type I protein expression in mice. Mardones P, Pilon A, Bouly M, Duran D, Nishimoto T, Arai H, Kozarsky KF, Altayo M, Miquel JF, Luc G, Clavey V, Staels B, Rigotti A, J Biol Chem 2003 278 7884 7890 10.1074/jbc.M211627200 12511553